A Study of Brepocitinib in Adults With Active Non-Infectious Non-Anterior Uveitis
Clinical trial NCT05523765 · COMPLETED
Trial details
- NCT number
- NCT05523765
- Sponsor
- Priovant Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-14
- Primary completion
- 2024-07-30
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.